Skip to main content
TipRanks
Go Ultimate75% OFF

Baird Medical Investment Holdings (BDMD) Stock Price & Analysis

71 Followers

BDMD Stock Chart & Stats

$0.09-$0.01(-13.59%)
At close: 4:00 PM EST
$0$0.5$1Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$0.09 - $0.10
52-Week Range
$0.07 - $3.70
Previous Close
$0.10
Volume
N/A
Average Volume (3M)
33.80M
Market Cap
$5.82M
Enterprise Value
$54.13M
Total Cash (Recent Filing)
$289.08K
Total Debt (Recent Filing)
$14.22M
Price to Earnings (P/E)
―
Beta
-0.33
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

H1 2026 Revenue And Profit Recovery

The H1 2026 rebound shows that international sales, licensing revenue, and lower operating expenses can materially improve results after the 2025 downturn. If sustained, this combination provides a stronger base for restoring profitability and funding expansion in subsequent reporting periods.

Medtech Portfolio And International Expansion

A portfolio spanning microwave ablation, IRE products, and robotic ablation gives BDMD multiple technology avenues within minimally invasive tumor treatment. Its expanding commercial presence outside China, including the U.S., supports broader market access and reduces reliance on one geography or product.

Manageable Reported Leverage

Reported debt remains below equity, which provides some balance-sheet support despite the recent loss and decline in equity. This cushion can help the company continue operating and pursue its strategy, although preserving it depends on improving profitability and cash generation.

Bears Say

Sharp 2025 Profitability Deterioration

The 2025 reversal indicates that prior profitability was not yet consistently durable, with revenue contraction accompanied by deeply negative operating and net margins. Continued earnings volatility could weaken reinvestment capacity, pressure equity, and make future performance more dependent on a successful operating recovery.

Persistent Negative Cash Generation

Repeatedly negative operating and free cash flow means the business has not been funding its needs internally across the periods shown. If this continues, BDMD may need additional external capital to sustain operations and expansion, increasing financial dependence and reducing flexibility in capital allocation.

Nasdaq Minimum-Bid Compliance Risk

The Nasdaq deficiency creates an ongoing listing-compliance requirement that can distract management and impose pressure to execute a share consolidation or other corrective action. Failure to regain compliance within the available periods could reduce trading access and complicate future financing.

Baird Medical Investment Holdings News

BDMD FAQ

What was Baird Medical Investment Holdings’s price range in the past 12 months?
Baird Medical Investment Holdings lowest stock price was $0.07 and its highest was $3.70 in the past 12 months.
What is Baird Medical Investment Holdings’s market cap?
Baird Medical Investment Holdings’s market cap is $5.82M.
When is Baird Medical Investment Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Baird Medical Investment Holdings’s earnings last quarter?
Baird Medical Investment Holdings released its earnings results on Sep 03, 2026. The company reported $0 earnings per share for the quarter, missing the consensus estimate of $0.04 by -$0.04.
Is Baird Medical Investment Holdings overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Baird Medical Investment Holdings pay dividends?
Baird Medical Investment Holdings does not currently pay dividends.
What is Baird Medical Investment Holdings’s EPS estimate?
Baird Medical Investment Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Baird Medical Investment Holdings have?
Baird Medical Investment Holdings has 56,518,770 shares outstanding.
What happened to Baird Medical Investment Holdings’s price movement after its last earnings report?
Baird Medical Investment Holdings reported an EPS of $0 in its last earnings report, missing expectations of $0.04. Following the earnings report the stock price went up 4.464%.
Which hedge fund is a major shareholder of Baird Medical Investment Holdings?
Hedge funds hold Baird Medical Investment Holdings shares: the largest hedge-fund position in Baird Medical Investment Holdings is 70,129,560 shares, and hedge funds decreased their holdings by 125.0K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology